Growth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086

WEB-2086 – an antagonist of platelet-activating factor receptor (PAFR) with known anti-inflammatory, antiangiogenic and antileukaemic properties – also proved to inhibit the proliferation in human solid tumour cell lines of different histology, and with much higher efficacy than in normal fibroblast...

Descripción completa

Detalles Bibliográficos
Autores principales: Cellai, C, Laurenzana, A, Vannucchi, A M, Caporale, R, Paglierani, M, Di Lollo, S, Pancrazzi, A, Paoletti, F
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361325/
https://www.ncbi.nlm.nih.gov/pubmed/16721373
http://dx.doi.org/10.1038/sj.bjc.6603156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361325/
https://www.ncbi.nlm.nih.gov/pubmed/16721373
http://dx.doi.org/10.1038/sj.bjc.6603156

Ejemplares similares